Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
Terminated
Sanofi
Phase 4
2003-12-30
This is a phase 4 clinical investigation of the efficacy and safety of Ferrlecit in the
maintenance of iron stores and serum hemoglobin concentration in hemodialysis patients
receiving Erythropoietin.
Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
Terminated
Watson Pharmaceuticals
Phase 4
2003-12-30
This is a phase 4 clinical investigation of the efficacy and safety of Ferrlecit in the
maintenance of iron stores and serum hemoglobin concentration in hemodialysis patients
receiving Erythropoietin.
Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients
Completed
Watson Pharmaceuticals
Phase 4
2003-06-01
This was a multi-center study in iron-deficient pediatric hemodialysis patients, whose legal
guardian had provided signed informed consent and satisfied the inclusion and exclusion
criteria.
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
Completed
Watson Pharmaceuticals
Phase 2/Phase 3
2003-12-01
This is a phase 3 clinical investigation. Patients who meet the eligibility criteria and
provide signed informed consent will be randomized to receive one of two levels of Ferrlecit
or oral iron in a 1:1:1 ratio.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
